(S1 (S (NP (NP (JJ Molecular) (NN cloning)) (PP (IN of) (NP (NP (NN globotriaosylceramide/CD77) (NN synthase)) (, ,) (NP (NP (DT a) (NN glycosyltransferase)) (SBAR (WHNP (WDT that)) (S (VP (VBZ initiates) (NP (NP (DT the) (NN synthesis)) (PP (IN of) (NP (NN globo) (NN series) (NNS glycosphingolipids)))))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (NN expression) (NN cloning)) (PP (IN of) (NP (NP (DT a) (NN cDNA)) (PP (IN for) (NP (NP (NN globotriaosylceramide) (-LRB- -LRB-) (NN Gb3) (-RRB- -RRB-) (NN /CD77) (NN synthase)) (PRN (-LRB- -LRB-) (NP (NN alpha1,4-galactosyltransferase)) (-RRB- -RRB-))))))) (VP (VBD was) (VP (VBN achieved) (S (VP (VBG using) (NP (NP (DT an) (JJ anti-Gb3) (NN antibody)) (CC and) (NP (NN mouse) (NN L) (NNS cells))) (PP (IN as) (NP (NP (DT a) (JJ recipient) (NN cell) (NN line)) (PP (IN for) (NP (DT the) (NN transfection)))))))))) (. .)))
(S1 (S (S (NP (NP (DT The) (VBN isolated) (NN cDNA) (NN clone)) (VP (VBN designated) (NP (NN pVTR1)))) (VP (VBD predicted) (NP (NP (DT a) (NN type) (CD II) (NN membrane) (NN protein)) (PP (IN with) (NP (NP (CD 19) (NN amino) (NNS acids)) (PP (IN of) (NP (NP (JJ cytoplasmic) (NN domain)) (, ,) (NP (NP (CD 26) (NN amino) (NNS acids)) (PP (IN of) (NP (NN transmembrane) (NN region)))) (, ,) (CC and) (NP (NP (DT a) (JJ catalytic) (NN domain)) (PP (IN with) (NP (CD 308) (NN amino) (NNS acids))))))))))) (. .)))
(S1 (S (S (S (NP (NP (NN Introduction)) (PP (IN of) (NP (DT the) (NN cDNA) (NN clone))) (PP (IN into) (NP (NN L) (NNS cells)))) (VP (VBD resulted) (PP (IN in) (NP (NP (DT the) (NN neosynthesis)) (PP (IN of) (NP (NN Gb3/CD77))))))) (, ,) (CC and) (S (NP (NP (DT the) (NNS extracts)) (PP (IN of) (NP (DT the) (JJ transfectant) (NNS cells)))) (VP (VBD showed) (NP (NN alpha1) (, ,) (NN 4-galactosyltransferase) (NN activity)) (PP (ADVP (RB only)) (IN on) (NP (NP (NN lactosylceramide)) (CC and) (NP (NN galactosylceramide))))))) (. .)))
(S1 (S (S (PP (IN In) (NP (NN Northern) (NN blotting))) (, ,) (NP (DT a) (JJ 2.3-kilobase) (NN mRNA)) (VP (VBD was) (ADVP (RB strongly)) (VP (VBN expressed) (PP (PP (IN in) (NP (NP (NN heart)) (, ,) (NP (NN kidney)) (, ,) (NP (NN spleen)) (, ,) (CC and) (NP (NN placenta)))) (CC and) (PP (ADVP (RB weakly)) (IN in) (NP (NP (NN colon)) (, ,) (NP (JJ small) (NN intestine)) (, ,) (CC and) (NP (NN brain)))))))) (. .)))
(S1 (S (S (NP (NP (NN Transfection)) (PP (IN of) (NP (DT the) (NN cDNA))) (PP (IN into) (NP (NN L) (NNS cells)))) (VP (VBD resulted) (PP (IN in) (NP (NP (DT the) (NN constitution)) (PP (IN of) (NP (NP (NN sensitivity)) (PP (TO to) (NP (DT the) (NN apoptosis))) (PP (IN with) (NP (NP (JJ Shiga-like) (NNS toxins)) (PRN (-LRB- -LRB-) (NP (NNS verotoxins)) (-RRB- -RRB-)))))))))) (. .)))
(S1 (S (S (SBAR (IN Since) (S (NP (NN Gb3/CD77) (NN synthase)) (VP (VBZ initiates) (NP (NP (DT the) (NN synthesis)) (PP (IN of) (NP (NN globo) (NN series) (NP (NNS glycolipids)))))))) (, ,) (NP (NP (DT the) (NN isolation)) (PP (IN of) (NP (DT this) (NN cDNA)))) (VP (MD will) (VP (VB make) (NP (NP (JJ possible) (JJ further) (NNS investigations)) (PP (IN into) (NP (NP (DT the) (NN function)) (PP (IN of) (NP (NP (PRP$ its) (JJ important) (NN series)) (PP (IN of) (NP (NN glycolipids))))))))))) (. .)))
